139 related articles for article (PubMed ID: 32373954)
1. ZEB2-AS1 regulates the expression of TAB3 and promotes the development of colon cancer by adsorbing microRNA-188.
Li YL; Zhang XX; Yao JN; Gao B; Gao SL; Wang CF; Zhou HN; Zhang LF
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4180-4189. PubMed ID: 32373954
[TBL] [Abstract][Full Text] [Related]
2. Effect and mechanism of long non-coding RNA ZEB2-AS1 in the occurrence and development of colon cancer.
Guo X; Jing YM; Lou HZ; Lou QA
Math Biosci Eng; 2019 Sep; 16(6):8109-8120. PubMed ID: 31698657
[No Abstract] [Full Text] [Related]
3. LncRNA ZEB2-AS1 promotes bladder cancer cell proliferation and inhibits apoptosis by regulating miR-27b.
Wu X; Yan T; Wang Z; Wu X; Cao G; Zhang C
Biomed Pharmacother; 2017 Dec; 96():299-304. PubMed ID: 28992472
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
Xu C; Cui H; Li H; Wu Y; An H; Guo C
J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
[TBL] [Abstract][Full Text] [Related]
5. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
Zhou Y; Feng D; Gu X; Gao A; Liu Y
Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-140 Represses Esophageal Cancer Progression via Targeting ZEB2 to Regulate Wnt/β-Catenin Pathway.
Yang S; Li X; Shen W; Hu H; Li C; Han G
J Surg Res; 2021 Jan; 257():267-277. PubMed ID: 32862055
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of ZEB2-AS1 inhibits cell proliferation, invasion and induces apoptosis in osteosarcoma by combining with EZH2.
Zhang B; Fan DB; Liu L; Qin Y; Feng DQ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6533-6539. PubMed ID: 32633340
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-155 and FOXP3 jointly inhibit the migration and invasion of colorectal cancer cells by regulating ZEB2 expression.
Yang LP; Lin Q; Mu XL
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6131-6138. PubMed ID: 31364113
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
[TBL] [Abstract][Full Text] [Related]
10. LEF-AS1 participates in occurrence of colorectal cancer through adsorbing miR-505 and promoting KIF3B expression.
Gong XY; Huang AL
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9362-9370. PubMed ID: 31773695
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of ZEB2-AS1 inhibits cell invasion and induces apoptosis in colorectal cancer.
Wu X; Zhu H; Xie Y; Gu X; Zhang L; Huang L
J BUON; 2020; 25(1):194-201. PubMed ID: 32277632
[TBL] [Abstract][Full Text] [Related]
12. IL-6 stimulates lncRNA ZEB2-AS1 to aggravate the progression of non-small cell lung cancer through activating STAT1.
Chen T; Li J; Zhou MH; Xu LJ; Pan TC
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3734-3740. PubMed ID: 32329850
[TBL] [Abstract][Full Text] [Related]
13. ZEB2-AS1 Accelerates Epithelial/Mesenchymal Transition Through miR-1205/CRKL Pathway in Colorectal Cancer.
Jiang Y; Liu G; Ye W; Xie J; Shao C; Wang X; Li X
Cancer Biother Radiopharm; 2020 Mar; 35(2):153-162. PubMed ID: 31755734
[No Abstract] [Full Text] [Related]
14. MiRNA-206 inhibits proliferation of renal clear cell carcinoma by targeting ZEB2.
Chen XF; Guo JF; Xu JF; Yin SH; Cao WL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7826-7834. PubMed ID: 31599407
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.
Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J
J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191
[TBL] [Abstract][Full Text] [Related]
16. LINC01615 activates ZEB2 through competitively binding with miR-3653-3p to promote the carcinogenesis of colon cancer cells.
Hu Z; Yang C; Guo S; Li Y; Li Y
Cell Cycle; 2022 Feb; 21(3):228-246. PubMed ID: 34965191
[TBL] [Abstract][Full Text] [Related]
17. The Long Noncoding RNA ZEB2-AS1 Contributes to Proliferation and Epithelial-to-Mesenchymal Transition of Osteosarcoma.
Yang J; Zou Y; Wu J; Chen B; Luo C; Chen X; Shen H; Luo L
Cancer Biother Radiopharm; 2023 Nov; 38(9):596-603. PubMed ID: 33085924
[No Abstract] [Full Text] [Related]
18. MiR-3653 inhibits the metastasis and epithelial-mesenchymal transition of colon cancer by targeting Zeb2.
Zhu W; Luo X; Fu H; Liu L; Sun P; Wang Z
Pathol Res Pract; 2019 Oct; 215(10):152577. PubMed ID: 31405759
[TBL] [Abstract][Full Text] [Related]
19. lncRNA ZEB2-AS1 Aggravates Progression of Non-Small Cell Lung Carcinoma via Suppressing PTEN Level.
Chen X; Wang K
Med Sci Monit; 2019 Nov; 25():8363-8370. PubMed ID: 31695021
[TBL] [Abstract][Full Text] [Related]
20. CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis.
Du Y; Liu X; Zhang S; Chen S; Guan X; Li Q; Chen X; Zhao Y
Reprod Biol Endocrinol; 2021 Nov; 19(1):176. PubMed ID: 34847936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
